Topicals are low barrier entry, microneedling can raise penetration, and injections or mesotherapy require clinic sterility and close follow-up
Metabolic effects may persist slightly longer, up to 8 weeks post-discontinuation
Medical history and medication review to flag any interactions or contraindications before prescribing Goal-specific protocol selection based on injury location, duration, and severity rather than a one-size-fits-all 500 mcg recommendation Written reconstitution and injection instructions with the exact mL and unit markings for the patients specific vial and prescribed dose Injection training for self-administration patients, either in-clinic or via telehealth video walkthrough Week-four check-in to assess response, adjust dose or frequency if needed, and confirm the patient is completing the cycle correctly Pharmacy-grade 503A product with verified purity, sterility, and potency from an FDA-registered compounding pharmacy For patients who have never injected a peptide before, we also review the BPC-157 benefits and mechanism in detail before starting the protocol so the patient understands what the peptide does, what to expect during the cycle, and what results realistically look like at four, eight, and twelve weeks
This preparation contains a total peptide content exceeding the labelled amount based on independent analytical verification
Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB)
